New York, NY – November 10, 2025 – The Dow Jones Industrial Average surged today, fueled by a wave of investor optimism surrounding a potential breakthrough deal to end the protracted U.S. government shutdown. After weeks of uncertainty and market apprehension, the prospect of a legislative resolution has injected a much-needed
Health insurer stocks fell after the Senate ended the shutdown without extending ACA subsidies, delaying the decision to December and raising premium concerns.
Wall Street rebounded on Monday, recovering part of last week's steep losses as investors grew more confident about risk assets amid encouraging signs from Washington that the record-long government shutdown may soon conclude.
In a surprising turn of events on November 10, 2025, UnitedHealth Group (NYSE: UNH), a titan in the healthcare industry, saw its stock tumble significantly, shedding several percentage points of its market capitalization. This downturn sharply contrasted with a generally buoyant market, where major indices like the S&P 500
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses.
November 6, 2025 – Humana Inc. (NYSE: HUM) shares experienced a significant downturn today, mirroring a broader negative trend across the market. While specific real-time triggers for this hypothetical date are beyond current predictive capabilities, the scenario points to a confluence of factors that could typically impact a major health insurer,
October 28, 2025, proved to be a day of significant upward momentum for several major players in the financial markets, as PayPal Holdings, Inc. (NASDAQ: PYPL), United Parcel Service (NYSE: UPS), and UnitedHealth Group (NYSE: UNH) each experienced substantial stock surges. These movements were catalyzed by a potent mix of
As the closing bell rings on October 27, 2025, the S&P 500 Healthcare sector stands at a critical juncture, exhibiting the nuanced volatility that defines this essential yet complex segment of the market. While specific daily performance metrics remain unreleased, today's trading likely saw the sector reacting to a
New York, NY – October 23, 2025 – The healthcare sector of the S&P 500 experienced a significant downturn today, conspicuously underperforming the broader market as a relentless surge in medical costs continues to erode the profitability of health insurers. This slump was epitomized by a dramatic sell-off in Molina Healthcare
Gold prices suffered a sharp correction on Tuesday as investors locked in profits following this year's explosive rally, while optimism across earnings kept industrial stocks powering higher and pushed the Dow Jones to fresh record highs.
Shares of health insurance provider Elevance Health (NYSE:EVH)
fell 3.2% in the morning session after the company reported third-quarter results showing that rising medical costs squeezed profits, despite an increase in revenue. Although operating revenue grew 12.4% year on year to $50.71 billion, the company's profitability declined. The operating gain in its Health Benefits segment reportedly fell sharply to $0.6 billion from $1.6 billion in the same period a year ago, driven by higher medical expenses. The company's benefit expense ratio—which measures how much of its premium revenue is spent on medical care—increased, with the rise attributed to cost trends in its Medicare business. As a result of these pressures, quarterly adjusted earnings per share dropped to $6.03 from $8.37 in the previous year's quarter, overshadowing the fact that both revenue and earnings beat Wall Street's expectations.
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Tuesday to find the gap up and gap down stocks in today's session.
Elevance Health (ELV) beat Q3 earnings and revenue estimates, driven by strategic acquisitions and premium growth. The stock rose on the strong results.
Health insurance provider Elevance Health (NYSE:EVH) announced better-than-expected revenue in Q3 CY2025, with sales up 12.4% year on year to $50.71 billion. Its non-GAAP profit of $6.03 per share was 22% above analysts’ consensus estimates.
